Nowadays it is very important to use optimized processes to make a biogas plant profitable. The production of biogas is a strongly grown market in the last 20 years. In the beginning biogas was produced from manure to get rid of the “waste” in an intelligent way. Today biogas is a very important energy source that depends mainly on two factors -cost of substrate and effectivity of the gas production.
Antibodies and antibody fragments (ABF) are most important, highly demanded tools in diagnostic and therapeutic applications with predicted sales of 56 billion dollars by 2012
Photobioreactors (PBRs) are increasingly being used to grow algae for production of biofuel and other products. Light and CO2 are two major limiting resources that can restrict algal growth in PBRs. Atmospheric CO2 is only 0.04% and to overcome this limitation researchers have started to couple biogas released from the anaerobic digestion (AD) of organic waste with PBRs since biogas consists of mostly CO2 and CH4.
The research in the group of Prof. Rolf Müller at Saarbrücken/Germany addresses the chemistry, biosynthesis, regulation, heterologous production and mode-of-action of secondary metabolites from myxobacteria. These soil-dwelling microbes are potent microbial producers of natural products, which show strong activities as antibiotics, anti-cancer drugs or immunosuppressants, amongst others.